ChemDiv, Inc. and Lilly have expanded their drug discovery collaboration through 2010. The two companies will identify and develop leads for an additional therapeutic target using ChemDiv’s small molecule resources and Discovery outSource platforms. The collaboration began in January 2004 to discover and develop leads and research tools across multiple therapeutic areas. With this agreement, Lilly has continued access to ChemDiv’s Discovery outSource services for preclinical and c...